Hereditary Testing Market
Hereditary Testing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Hereditary Testing Market Size and Growth
The hereditary testing market is experiencing robust growth, driven by rising awareness of genetic disorders and advances in technology. As of 2023, the market size is estimated to reach USD 10 billion, fueled by increasing demand for personalized medicine and enhanced preventive healthcare strategies. Key segments include oncology and cardiovascular testing. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Myriad Genetics, Inc.
◍ Invitae Corporation
◍ Illumina, Inc.
◍ Natera, Inc.
◍ Laboratory Corporation of America Holdings
◍ F. Hoffmann-La Roche Ltd
◍ Quest Diagnostics Incorporated
◍ CooperSurgical, Inc.
◍ Agilent Technologies, Inc.
◍ Thermo Fisher Scientific, Inc.
◍ Twist Bioscience
◍ Sophia Genetics
◍ Fulgent Genetic, Inc.
◍ Medgenome
◍ CENTOGENE
The hereditary testing market features key players like Myriad Genetics, Invitae, and Illumina, offering genetic tests for inherited conditions. These companies innovate to enhance testing accuracy, expand test menus, and increase accessibility. Revenue highlights include Myriad ($B), Invitae ($B), and LabCorp ($B), contributing to market growth and awareness.
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Laboratory
Others
Request Sample Report
By Product
Hereditary Cancer Testing
Hereditary Non-cancer Testing
Market Growth
Request Sample Report
$ X Billion USD
